TheJobsMapOncoVanta Therapeutics jobs and careers
As of October 23, 2026, OncoVanta Therapeutics has no open roles listed.
About OncoVanta Therapeutics
OncoVanta Therapeutics is a biotechnology company pioneering next-generation immunotherapies targeting mutant p53, the most frequently altered gene in human cancers. More than 50% of all tumors harbor TP53 mutations, yet no approved therapies directly address this major unmet medical need. Leveraging NIH-derived TCR (T- cell receptor) assets and cutting edge cell therapy platforms, OncoVants is advancing a novel pipeline of TCR-based adoptive cell therapies designed to selectively target hotspot p53 mutations in solid tumors. Our Mission is clear; turn breakthrough science into life-saving medicines for patients with hard-to treat cancers. Specialties: • Adoptive Cell Therapy (ACT) • T Cell Receptor (TCR) Engineering • p53 Mutant Oncology • Immuno-Oncology (I/O) • Translational Research &; Development • Biotech Partnerships & Licensing
- Employees
- 1 to 10
Leadership
The top of OncoVanta Therapeutics's org chart, with how many people report into each leader.
Roman Owens
Founder & Chief Executive Officer | OncoVanta Therapeutics, Inc
Jobs at OncoVanta Therapeutics
No open positions right now. Explore more companies on TheJobsMap.
OncoVanta Therapeutics jobs: common questions
- Is OncoVanta Therapeutics hiring right now?
- OncoVanta Therapeutics has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on OncoVanta Therapeutics's careers site.
- Who leads OncoVanta Therapeutics?
- Roman Owens, Founder & Chief Executive Officer | OncoVanta Therapeutics, Inc, is at the top of OncoVanta Therapeutics's org chart.
- How do I apply for a job at OncoVanta Therapeutics?
- Pick a role on OncoVanta Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on OncoVanta Therapeutics's own careers site, so you apply directly with the employer.